Capital Research Global Investors grew its position in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 795,909 shares of the company’s stock after buying an additional 3,123 shares during the quarter. Capital Research Global Investors owned 1.47% of Molina Healthcare worth $138,122,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently modified their holdings of the company. AQR Capital Management LLC raised its holdings in shares of Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after purchasing an additional 2,008,458 shares during the period. Victory Capital Management Inc. raised its holdings in shares of Molina Healthcare by 344.3% in the 3rd quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock worth $184,380,000 after purchasing an additional 746,639 shares during the period. Norges Bank bought a new stake in shares of Molina Healthcare in the 4th quarter worth approximately $109,766,000. UBS Group AG raised its holdings in shares of Molina Healthcare by 320.7% in the 3rd quarter. UBS Group AG now owns 603,934 shares of the company’s stock worth $115,569,000 after purchasing an additional 460,372 shares during the period. Finally, Viking Global Investors LP bought a new stake in shares of Molina Healthcare in the 2nd quarter worth approximately $79,665,000. Institutional investors own 98.50% of the company’s stock.
Analysts Set New Price Targets
A number of research firms recently commented on MOH. Wells Fargo & Company lifted their price target on shares of Molina Healthcare from $141.00 to $159.00 and gave the stock an “equal weight” rating in a report on Monday, April 27th. Truist Financial lifted their price target on shares of Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a report on Monday, May 11th. UBS Group lifted their price target on shares of Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a report on Friday, May 22nd. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Molina Healthcare in a report on Tuesday, April 21st. Finally, Barclays lifted their price target on shares of Molina Healthcare from $161.00 to $199.00 and gave the stock an “underweight” rating in a report on Tuesday, May 26th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $182.73.
Molina Healthcare Stock Up 3.9%
Molina Healthcare stock opened at $198.34 on Tuesday. The firm has a 50 day simple moving average of $169.59 and a 200 day simple moving average of $162.97. The firm has a market capitalization of $10.33 billion, a price-to-earnings ratio of 58.68 and a beta of 0.80. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $311.52.
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same period in the previous year, the business earned $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, analysts predict that Molina Healthcare, Inc will post 5.23 earnings per share for the current year.
Insiders Place Their Bets
In other news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is owned by insiders.
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Further Reading
- Five stocks we like better than Molina Healthcare
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
